Journals / Retina-Vitreus / 2017 / Cilt: 26 - Sayı: 1

Evaluation of Optic Neuritis Patients With Ishihara and Farnsworth-Munsell 100-Hue Tests

Optik Nevrit Hastalarının Ishihara ve Farnsworth-Munsell 100-Hue Testi ile Değerlendirilmesi

Pages
32–34
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The difference between ishıhara and F-M 100-Hue test can be explained by that ishihara test is a pseudoisochromatic test and is not sensitive enough to quantify the acquired color vision pathologies.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: In optic neuritis patients, vision recovers after an active period while phsycophysical tests rernain to be defective.
📊
Key Findings & Data:Color vision was tested with two separate procedures in these patientsMaterial and Method: In our neuro-opthalmology department, 18 eyes of the 15 patients who had previous optic neuritis history were evaluated for color vision with Ishihara and Farnsworth-Munsell 100 Hue test (F-M 100-Hue test).Results: Color vision was normal and near to the normal with Ishihara test in all patients.
💡
Conclusion & Impact:The difference between ishıhara and F-M 100-Hue test can be explained by that ishihara test is a pseudoisochromatic test and is not sensitive enough to quantify the acquired color vision pathologies.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: In optic neuritis patients, vision recovers after an active period while phsycophysical tests rernain to be defective. Color vision was tested with two separate procedures in these patientsMaterial and Method: In our neuro-opthalmology department, 18 eyes of the 15 patients who had previous optic neuritis history were evaluated for color vision with Ishihara and Farnsworth-Munsell 100 Hue test (F-M 100-Hue test).Results: Color vision was normal and near to the normal with Ishihara test in all patients. However color vision defect was recorded with F-M 100-Hue test which was not definable by a specific pattern.Conclusion: In optic neuritis patients although vision decreased slightly, color vision is impaired obviously. After the active period, the visual acuity recovers to normal and near to normal values while color vision remains defective. The difference between ishıhara and F-M 100-Hue test can be explained by that ishihara test is a pseudoisochromatic test and is not sensitive enough to quantify the acquired color vision pathologies.

Özet

Amaç: Optik nevrit hastalarında, atak sonrası görme keskinliği genellikle düzelmesine rağmen psikofiziksel testlerdeki bozukluklar devam etmektedir. Bu hastalarda renkli görme iki farklı yöntemle test edildi.Gereçe ve Yöntem: Nörooftalmoloji birimimizde, geçirilmiş optik nevrit hikayesi olan, 15 olgunun 18 gözünde Ishıhara ve Farnsworth-Munsell 100 Hue testi (F-M 100-Hue test) ile renkli görme muayenesi yapıldı.Bulgular: Ishihara testi ile renkli görme, normal veya normale yakınken; hastaların hepsinde F-M 100-Hue testi ile belli bir paterne uymayan renkli görme defekti tespit edildi. Sonuç: Optik nevrit hastalarında atak sırasında görme azalması belirgin olmasa da renkli görme bozulur. Atak sonrası dönemde ise görme keskinliği normal veya normale yakın değerlere dönerken, renkli görmedeki bozukluk devam etmektedir. Ishihara ve F-M 100-Hue testi arasındaki sonuçların farklı olması, bir pseudoizokromatik test olan Ishihara'nın edinsel renk görme patolojilerini ortaya çıkarmada yetersizliği ile açıklanabilir.

🔖

Cite This Article

HAMURCU, M. Ş., SARICAOĞLU, M. S., DURMUŞ, B. Ş. (2017). Evaluation of Optic Neuritis Patients With Ishihara and Farnsworth-Munsell 100-Hue Tests. Retina-Vitreus, Cilt: 26 - Sayı: 1, 32–34. https://ajindex.com/articles/307618

References (14)

  1. Hoyt TJ. Neuro-ophthalmology. Lea et Febiger. Philadelphia 1992; 397-491
  2. Wall M. Multipl sklerosis. In Albert DM, Jacobiec FA. Principles and Practice of ophthalmology. WB Saunder Co Philadelphia 1994; Vol IV:2682-8
  3. Hamurcu MŞ, Kalaycı D, Şengün A. Evaluation of the cases of nonarteritic ischemic optic neuropathy and optic neuritis. MN Oftalmoloji 2001;8:388-91 4. Hamurcu MŞ, Orhan G, Kalaycı D, et al. Evaluation of the vision system in multiple sclerosis patients. MN Oftalmoloji, 2007,14:163-166
  4. Glaser JS. Neuro-ophthalmology JB Lippincott. Company. Philadelphia 1990; 83-170
  5. Katz B. The dyschromatopsia of optic neuritis: a descriptive analysis of data from the optic neuritis treatment trial. Trans Am Ophthalmol Soc 1995; 93: 685-708
  6. Rizzo III JF, Lessell S. Optic neuritis and ischemic optic neuropathy. Overlapping clinical profiles. Arch Ophthalmol 1991; 109: 1668-1672
  7. Griffin JF, Wra y SH. Acquired color vision defects in retrobulber neuritis. Am J Ophthalmol 1978;86:193-201
  8. Harrison A C, Becker W J, Stell W K. Color vision abnormalities in multipl sclerosis. Can J Neurol Sci 1987; 14:279-85
  9. Schneck ME, Haegerstrom-Portnoy G. Color vision defect type and spatial vision in the optic neuritis treatment trial. Invest Ophthalmol Vis Sci 1997; 38: 2278-2289
  10. Nichols BE, Thompson HS, Stone EM. Evaluation of a significantly shorter version of the Farnsworth-Munsell 100-hue test in patients with three different optic neuropathies. J Neurol.1997;17:1-6
  11. Trobe JD, Beck RW, Moke PS, et al. Contrast sensitivity and other vision tests in the optic neuritis treatment trial. Am J Ophthalmol. 1996;121:547-53
  12. Ménage MJ, Papakostopoulos D, Dean Hart JC, et al. The Farnsworth-Munsell 100 hue test in the first episode of demyelinating optic neuritis. Br J Ophthalmol. 1993;77:68-74 14. Ghose S, Shrey D, Venkatesh P, Parmar T, Sharma S. A simple modification of the Farnsworth-Munsell 100-hue test for much faster assessment of color vision. Indian J Ophthalmol. 2014; 62(6):721-3
  13. Melamud A, Simpson E, Traboulsi EI. Introducing a new computer-based test for the clinical evaluation of color discrimination Am J Ophthalmol. 2006;142(6):953-60
  14. Gundogan FC, Tas A, Altun S, Oz O, Erdem U, Sobaci G. Color vision versus pattern visual evoked potentials in the assessment of subclinical optic pathway involvement in multiple sclerosis. Indian J Ophthalmol. 2013;61(3):100-3.